Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Periostin: An emerging biomarker for allergic diseases.
Izuhara K, Nunomura S, Nanri Y, Ono J, Takai M, Kawaguchi A. Izuhara K, et al. Among authors: nunomura s. Allergy. 2019 Nov;74(11):2116-2128. doi: 10.1111/all.13814. Epub 2019 May 3. Allergy. 2019. PMID: 30964557 Review.
The FADS mouse: A novel mouse model of atopic keratoconjunctivitis.
Nunomura S, Kitajima I, Nanri Y, Kitajima M, Ejiri N, Lai IS, Okada N, Izuhara K. Nunomura S, et al. J Allergy Clin Immunol. 2021 Dec;148(6):1596-1602.e1. doi: 10.1016/j.jaci.2021.05.017. Epub 2021 May 25. J Allergy Clin Immunol. 2021. PMID: 34048854
Periostin in inflammation and allergy.
Izuhara K, Nunomura S, Nanri Y, Ogawa M, Ono J, Mitamura Y, Yoshihara T. Izuhara K, et al. Among authors: nunomura s. Cell Mol Life Sci. 2017 Dec;74(23):4293-4303. doi: 10.1007/s00018-017-2648-0. Epub 2017 Sep 8. Cell Mol Life Sci. 2017. PMID: 28887633 Free PMC article. Review.
Expression profile of periostin isoforms in systemic sclerosis.
Nanri Y, Nunomura S, Watanabe T, Ohta S, Yamaguchi Y, Izuhara K. Nanri Y, et al. Among authors: nunomura s. J Dermatol Sci. 2021 Dec;104(3):210-212. doi: 10.1016/j.jdermsci.2021.10.005. Epub 2021 Oct 21. J Dermatol Sci. 2021. PMID: 34782190 No abstract available.
Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B-PAD study).
Nakahara T, Izuhara K, Onozuka D, Saeki H, Nunomura S, Takenaka M, Matsumoto M, Kataoka Y, Fujimoto R, Kaneko S, Morita E, Tanaka A, Hide M, Okano T, Miyagaki T, Aoki N, Nakajima K, Ichiyama S, Kido-Nakahara M, Tonomura K, Nakagawa Y, Tamagawa-Mineoka R, Masuda K, Takeichi T, Akiyama M, Ishiuji Y, Katsuta M, Kinoshita Y, Tateishi C, Yamamoto A, Morita A, Matsuda-Hirose H, Hatano Y, Kawasaki H, Tanese K, Ohtsuki M, Kamiya K, Kabata Y, Abe R, Mitsui H, Kawamura T, Tsuji G, Katoh N, Furue M. Nakahara T, et al. Among authors: nunomura s. Clin Exp Allergy. 2023 Feb;53(2):233-238. doi: 10.1111/cea.14267. Epub 2022 Dec 16. Clin Exp Allergy. 2023. PMID: 36524532 No abstract available.
The potential for repositioning antithyroid agents as antiasthma drugs.
Suzuki S, Ogawa M, Ohta S, Arima K, Nunomura S, Nanri Y, Mitamura Y, Yoshihara T, Nakamura Y, Yamauchi K, Chibana K, Ishii Y, Lee JJ, Aratani Y, Kakuta S, Kubo S, Iwakura Y, Yoshida H, Izuhara K. Suzuki S, et al. Among authors: nunomura s. J Allergy Clin Immunol. 2016 Nov;138(5):1458-1461.e8. doi: 10.1016/j.jaci.2016.04.047. Epub 2016 Jun 15. J Allergy Clin Immunol. 2016. PMID: 27444178 No abstract available.
130 results